0001415889-18-001202.txt : 20180801
0001415889-18-001202.hdr.sgml : 20180801
20180801160526
ACCESSION NUMBER: 0001415889-18-001202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180730
FILED AS OF DATE: 20180801
DATE AS OF CHANGE: 20180801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curran Terrie
CENTRAL INDEX KEY: 0001690298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18984746
MAIL ADDRESS:
STREET 1: C/O MYOVANT SCIENCES INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-08012018_040811.xml
X0306
4
2018-07-30
0000816284
CELGENE CORP /DE/
CELG
0001690298
Curran Terrie
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
false
true
false
false
SEE REMARKS
Stock Option (right to buy)
88.91
2018-07-30
4
A
0
12983
0
A
2028-07-30
Common Stock
12983
12983
D
Option is immediately exercisable and will vest in four equal annual installments commencing on July 30, 2019.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
President, Inflammation and Immunology
/s/ Mark J. Alles, Attorney-in-Fact
2018-08-01